AHA Coding Clinic® for HCPCS - 2014 Issue 2; For your information

Reporting instructions for GAZYVA (obinutuzumab)

GAZYVA™ (obinutuzumab ) injection for intravenous use in combination with chlorambucil, was approved by the U.S. Food and Drug Administration (FDA), for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL). For facility reporting, the drug must be billed using C9399 and the drug information should be entered in the “Remarks” section of the UB-04 or electronic equivalent. Please note: As of April 1, 2014, HCPCS code C9021, Injection, obinutuzumab, 10 mg, should be used to report GAZYVA (obinutuzumab) for facility reporting. ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.